ReviewThe Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology2024

Finerenone: a breakthrough mineralocorticoid receptor antagonist for heart failure, diabetes and chronic kidney disease.

Akshyaya Pradhan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.